MX163518B - Mejoras en un dispositivo osmotico con doble actividad termodinamica para suministrar a un regimen controlado un agente benefico - Google Patents

Mejoras en un dispositivo osmotico con doble actividad termodinamica para suministrar a un regimen controlado un agente benefico

Info

Publication number
MX163518B
MX163518B MX200502A MX20050284A MX163518B MX 163518 B MX163518 B MX 163518B MX 200502 A MX200502 A MX 200502A MX 20050284 A MX20050284 A MX 20050284A MX 163518 B MX163518 B MX 163518B
Authority
MX
Mexico
Prior art keywords
supply
beneficial agent
osmotic device
thermodynamic activity
controlled regime
Prior art date
Application number
MX200502A
Other languages
English (en)
Spanish (es)
Inventor
Patrick S L Wong
Brian Barclay
Joseph C Deters
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX163518(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of MX163518B publication Critical patent/MX163518B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
MX200502A 1983-05-11 1984-02-29 Mejoras en un dispositivo osmotico con doble actividad termodinamica para suministrar a un regimen controlado un agente benefico MX163518B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (1)

Publication Number Publication Date
MX163518B true MX163518B (es) 1992-05-25

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
MX200502A MX163518B (es) 1983-05-11 1984-02-29 Mejoras en un dispositivo osmotico con doble actividad termodinamica para suministrar a un regimen controlado un agente benefico

Country Status (20)

Country Link
JP (1) JPS6041609A (enFirst)
AT (1) AT397180B (enFirst)
AU (1) AU566110B2 (enFirst)
BE (1) BE898819A (enFirst)
CA (1) CA1222950A (enFirst)
CH (1) CH669329A5 (enFirst)
DE (1) DE3417113A1 (enFirst)
DK (1) DK163910C (enFirst)
ES (1) ES532018A0 (enFirst)
FR (1) FR2545721B1 (enFirst)
GB (1) GB2140687B (enFirst)
IE (1) IE56515B1 (enFirst)
IL (1) IL71727A (enFirst)
IT (1) IT1178911B (enFirst)
MX (1) MX163518B (enFirst)
NL (1) NL192250C (enFirst)
NO (1) NO170834C (enFirst)
NZ (1) NZ206600A (enFirst)
SE (1) SE455918B (enFirst)
ZA (1) ZA842422B (enFirst)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (ja) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド 調節された方法による有効成分の放出を可能にする医薬組成物
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
ES8800043A1 (es) * 1985-08-16 1987-10-16 Alza Corp Un dispositivo distribuidor para descargar una formulacion de agente beneficioso a un entorno de uso
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
ES2037179T3 (es) * 1987-11-25 1993-06-16 American Cyanamid Company Sistema de liberacion sostenida (controlada) para bloqueadores de canales de calcio de dihidropiridina.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5876752A (en) * 1990-08-07 1999-03-02 Pfizer Inc. Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
CA2089738C (en) * 1990-09-28 1997-01-21 Avinash Govind Thombre Dispensing device containing a hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
DE69426997T2 (de) * 1993-02-23 2001-11-15 Heikki Sirkkola Die Verwendung eines Calciumpräparates in einem Medikament zur Behandlung von an Hypocalcämie leidenden Milchkühen
US6440457B1 (en) * 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
CN101653411A (zh) * 2000-10-30 2010-02-24 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (de) 2001-06-20 2003-01-02 Bayer Ag Kombinationstherapie substituierter Oxazolidinone
DE10300111A1 (de) 2003-01-07 2004-07-15 Bayer Healthcare Ag Verfahren zur Herstellung von 5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophencarboxamid
WO2005039481A2 (en) * 2003-09-19 2005-05-06 Sun Pharmaceutical Industries Limited Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (de) 2003-11-27 2005-06-23 Bayer Healthcare Ag Verfahren zur Herstellung einer festen, oral applizierbaren pharmazeutischen Zusammensetzung
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (de) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
DE102005045518A1 (de) 2005-09-23 2007-03-29 Bayer Healthcare Ag 2-Aminoethoxyessigsäure-Derivate und ihre Verwendung
CA2823159C (en) 2005-10-04 2014-10-21 Bayer Intellectual Property Gmbh Polymorphic form of 5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide
DE102005047561A1 (de) 2005-10-04 2007-04-05 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit schneller Wirkstofffreisetzung
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
BRPI0925100A2 (pt) * 2009-06-02 2016-07-19 Dow Global Technologies Llc forma de dosagem osmótica e processo para preparar uma forma de dosagem osmótica
DE102011007272A1 (de) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Verzweigte 3-Phenylpropionsäure-Derivate und ihre Verwendung
EP2846777B1 (en) 2012-05-07 2016-10-26 Bayer Pharma Aktiengesellschaft Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil
UY34856A (es) 2012-07-03 2013-12-31 Bayer Pharma AG Formas de presentación farmacéuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4- morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofencarboxamida
JP5941117B2 (ja) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー 徐放製剤
EP3826627B1 (de) 2018-07-24 2023-10-18 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
WO2020020790A1 (de) 2018-07-24 2020-01-30 Bayer Aktiengesellschaft Oral applizierbare pharmazeutische darreichungsform mit modifizierter freisetzung
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE376851B (enFirst) * 1971-01-13 1975-06-16 Alza Corp
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Also Published As

Publication number Publication date
ES8503503A1 (es) 1985-03-01
NL192250C (nl) 1997-04-03
IL71727A0 (en) 1984-09-30
FR2545721B1 (fr) 1987-11-06
CA1222950A (en) 1987-06-16
AU2251183A (en) 1984-11-15
AT397180B (de) 1994-02-25
NZ206600A (en) 1987-01-23
IE56515B1 (en) 1991-08-28
DK99784D0 (da) 1984-02-24
CH669329A5 (enFirst) 1989-03-15
GB2140687B (en) 1987-03-18
SE8402512L (sv) 1984-11-12
DK163910B (da) 1992-04-21
SE455918B (sv) 1988-08-22
ATA88084A (de) 1993-07-15
IT8467283A0 (it) 1984-03-23
GB2140687A (en) 1984-12-05
DE3417113A1 (de) 1984-11-15
ZA842422B (en) 1984-11-28
DK99784A (da) 1984-11-12
NL192250B (nl) 1996-12-02
IE840010L (en) 1984-11-11
NO840248L (no) 1984-11-12
DE3417113C2 (enFirst) 1989-02-02
BE898819A (fr) 1984-05-30
GB8334189D0 (en) 1984-02-01
NO170834C (no) 1992-12-16
AU566110B2 (en) 1987-10-08
IL71727A (en) 1989-01-31
IT8467283A1 (it) 1985-09-23
DK163910C (da) 1992-09-14
NL8401470A (nl) 1984-12-03
IT1178911B (it) 1987-09-16
SE8402512D0 (sv) 1984-05-09
FR2545721A1 (fr) 1984-11-16
ES532018A0 (es) 1985-03-01
NO170834B (no) 1992-09-07
JPS6041609A (ja) 1985-03-05
JPH0575725B2 (enFirst) 1993-10-21

Similar Documents

Publication Publication Date Title
MX163518B (es) Mejoras en un dispositivo osmotico con doble actividad termodinamica para suministrar a un regimen controlado un agente benefico
MX165227B (es) Un dispositivo osmotico para suministrar un medicamento benefico a un entorno
BR7703297A (pt) Aperfeicoamento em armacao para confinar um colchao enchido com agua de um leito de colchao de agua e aperfeicoamento em leito dotado de colchao de agua
AR240398A1 (es) Dispositivo para administrar un agente beneficial a un animal
IT963851B (it) Controllo della schiuma nella tintora a getto
ES511541A0 (es) "perfeccionamientos en aparatos para almacenar energia".
BR7703782A (pt) Aperfeicoamentos na ancoragem das pas do estator em compressores axiais
AR220141A1 (es) Soporte para ser usado en combinacion con un continente
IT976591B (it) Caldaia in particolare marmitta con intercapedine a pressione
JPS5322904A (en) Turbine for use in compressible fluid
BE797861A (fr) Soupape d'arret a servo-piston
ES196782Y (es) Una estructura de taco de plastico de una pieza para su usoen un cartucho.
FR2513025B1 (fr) Laser notamment laser a circulation de gaz co2
JPS52137503A (en) Device for supervise fuel supply volume and water supply volume in onceethrough boiler
MX145018A (es) Mejoras en metodo para reparar una tuberia sub-acuatica
ES284622Y (es) Dispositivo para preparar y suministrar una solucion.
BR7305683D0 (pt) Aperfeicoamentos em um refrigerador
AT357102B (de) Lagerkasten, insbesondere zum einstellen in regale
MX145628A (es) Mejoras en unidad amortiguadora para un tanque de almacenamiento globular
BR7603377A (pt) Desprendedor em um embolo que pode ser introduzido em um recipiente
IT7920463V0 (it) Struttura di poltrona componibile trasformabile in letto.
BR7306496D0 (pt) Uma bucha para uso em broca dental
ES536195A0 (es) Un aparato para mejorar la termotransparencia en un termointercambiador.
SE417505B (sv) Dikarboxi-alkyleter till anvendning som uppbyggnadsmedel i detergentkompositioner samt anvendning derav
BR7702868A (pt) Aperfeicoamentos em estrutura para admitir um agente de refrigeracao numa turbo-maquina e na respectiva turbo-maquina